Article Abstract

Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors

Authors: Hirva Mamdani, Shadia I. Jalal


The past decade has witnessed a paradigm shift in the treatment of cancer, moving from ‘one size fits all’ to a more precision medicine-based approach owing to the development of molecular diagnostic technologies capable of identifying an increasing number of actionable genomic alterations in the tumor tissue and circulating tumor DNA.

Article Options

Download Citation